TC BioPharm (Holdings) PLC (TCBP)
1.49
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 13:25
TC BioPharm Cash from Operations (TTM): -13.16M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -13.16M |
June 30, 2023 | -15.72M |
Date | Value |
---|---|
December 31, 2022 | -18.70M |
June 30, 2022 | -13.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-18.70M
Minimum
Dec 2022
-13.16M
Maximum
Dec 2023
-15.37M
Average
-14.81M
Median
Cash from Operations (TTM) Benchmarks
Adaptimmune Therapeutics PLC | -140.88M |
Biodexa Pharmaceuticals Plc | -8.515M |
NuCana PLC | -32.90M |
Autolus Therapeutics PLC | -145.59M |
Mereo BioPharma Group PLC | -21.13M |